BRISTOL, Tenn., Feb. 23 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc. reported today that the Company will provide a live internet webcast and conference call following King's announcement of earnings for the fourth quarter and year ending December 31, 2005. As previously announced, King plans to announce earnings for the fourth quarter and year ending December 31, 2005 prior to the market open on Tuesday, February 28, 2006.
Two Ways to Join the Live Event - Tuesday, February 28, 2006, 1:00 pm, Eastern Standard Time
Internet Webcast:
Click the following link to register, then join the live event with the same URL:
http://hpbroadband.com/program.cfm?key=KingPharmaQ4Earnings Telephone Audio Conference: Call in to the telephone conference up to 15 minutes early: Toll free in the United States 800-903-0258 Outside the US 785-832-1508 Passcode 7HP6312 Can't Make the Live Event? Listen "On-Demand":
If you are unable to participate during the live event, the call will be archived on King's web site www.kingpharm.com for not less than 14 days following the call.
King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect management's current views of future events and operations, including, but not limited to, statements pertaining to the anticipated date for release of the Company's financial results for the fourth quarter and year ending December 31, 2005. These forward-looking statements involve certain significant risks and uncertainties, and actual results may differ materially from the forward- looking statements. Some important factors which may cause results to differ include: dependence on King's ability to release the Company's financial results for fourth quarter and year ending December 31, 2005 as currently planned on February 28, 2006. Other important factors that may cause actual results to differ materially from the forward-looking statements are discussed in the "Risk Factors" section and other sections of King's Form 10-K for the year ended December 31, 2004 and Form 10-Q for the third quarter ended September 30, 2005, which are on file with the Securities and Exchange Commission. King does not undertake to publicly update or revise any of its forward-looking statements even if experience or future changes show that the indicated results or events will not be realized.
King Pharmaceuticals, Inc.
CONTACT: James E. Green, Executive Vice President, Corporate Affairs,+1-423-989-8125, or David E. Robinson, Senior Director, Corporate Affairs,+1-423-989-7045, both of King Pharmaceuticals, Inc.
